missing translation for 'onlineSavingsMsg'
Learn More
Learn More
DiscoverX PathHunter™ eXpress BLK Activity Assay
Description
The PathHunter™ eXpress BLK Activity Assay provides an easy-to-use cell based assay to study small molecule drug candidates targeting CTKs. This kit assesses CTK activation via detection of resulting GHR phosphorylation-induced SH2 domain protein recruitment, mediated by BLK-JAK2 fusion protein. This product uses EFC technology. The included cells overexpress PK-tagged relevant cytokine receptor and EA-tagged SH2 domain protein alongside an engineered fusion of the cytokine receptor binding domain of JAK2 (Janus Kinase 2) to the catalytic domain from the CTK of interest, BLK. Upon activation of the cytokine receptor, the CRBD-CTK fusion phosphorylates the receptor, leading to SH2-EA recruitment and production of EFC signal. eXpress kits are a convenient, ready-to-use format which contains all materials needed to run the assay, including single-use vials of cryopreserved cells, cell plating media, detection reagent, and assay plates.
Specifications
Specifications
| Assay Entry | SH2 recruitment |
| For Use With (Application) | Assay-Ready eXpress Kits |
| Primary Agonist | Recombinant Human Growth Hormone |
| Quantity | 200 dp (2 x 96-well) |
| Target Entry | BLK |
| Cell Line | U2OS |
| Target | BLK |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?